香港, 2025年3月3日 - (亚太商讯 via SeaPRwire.com) - 近年来，中国汽车产业链在资本市场上动作频频，诸多重量级 IPO 相继登场。从"蔚小理"造车新势力到地平线等智驾领域明星企业，再到宁德时代，中国汽车产业的资本化进程不断加速。2月28日，国内唯一未上市的大型汽车集团奇瑞汽车正式向港交所递表，拟在主板挂牌。中金、华泰及广发担任联席保荐人。奇瑞汽车是中国自主品牌乘用车的领军企业之一，以截至2024年9月30日止九个月的全球销量计算，是中国第二大自主品牌乘用车公司和全球第十一大乘用车公司。若成功在港上市，奇瑞汽车预计将成为近年来汽车行业体量最大的 IPO。构筑多元产品矩阵，推动品牌持续攀升在汽车行业，产品力是品牌价值的核心。凭借多年业务深耕所积累的技术专长及业务能力，奇瑞汽车构筑了多元化的产品矩阵，拥有奇瑞、捷途、星途、iCAR和智界五大品牌。其中，奇瑞品牌以高性价比和广泛适用性，奠定了坚实的市场基础；捷途聚焦旅行+概念，开拓细分市场；星途主打高端智能，进一步提升品牌形象；iCAR 专注新能源个性化，满足年轻群体的独特需求；智界则主攻新能源高端市场。各品牌定位清晰，相互补充，共同构成奇瑞汽车强大的品牌矩阵，并呈持续攀升之势。根据全球消费者洞察和市场研究公司君迪的排名，在2023年和2024年中国新车质量研究中，奇瑞品牌连续两年位居中国自主乘用车品牌第一。从销量数据来看，奇瑞汽车各品牌均呈现出强劲的增长态势。2024 年首九个月，奇瑞品牌销量同比增长 36.0%，捷途品牌销量更是实现翻倍增长，星途、iCAR 和智界也都在各自细分市场取得显著突破。不仅如此，品牌力的提升还让奇瑞汽车在乘用车行业竞争加剧的背景下，实现更高的产品定价。2024年首九个月，公司平均整车销售单价较2022年度增长32.9%。全球化战略大获成功，深入打开海外市场在车企出海浪潮中，奇瑞汽车同样走在前列。公司早在 2001 年就开启出海步伐，已在全球范围内建立了研发、生产和销售网络。研发方面，公司已在欧洲、南美及北美以及东南亚建立研发中心，深入了解当地市场需求和技术趋势。生产方面，在亚洲、欧洲、非洲及南美洲等海外市场扩大产能，提升市场回应速度。此外，公司还建立了广泛且有效的销售网络，截至2024年9月30日，拥有1,075家海外经销商，排名中国自主品牌乘用车公司前列。这种"从研发到生产再到销售"的全链路布局，既为奇瑞汽车在海外市场赢得先发优势，更使其成为中国汽车品牌出海的典范。自2003年起，奇瑞汽车连续22年乘用车出口量排名中国自主品牌乘用车公司第一。2024年首九个月，奇瑞汽车海外市场收入占比达44.0%，占据近半壁江山。在欧洲、南美和中东及北非地区，奇瑞汽车乘用车销量位列中国自主品牌乘用车公司第一。此次奇瑞汽车赴港上市，对中国汽车产业发展意义重大。它不仅是奇瑞汽车走向资本国际化的重要里程碑，也代表着中国汽车的全球化之路又迈出坚实一步。通过IPO，公司将构建国际化资本运作平台，提升品牌国际影响力，助力公司持续打造中国汽车品牌出海的优秀样本，推动中国汽车产业在全球市场上不断向前。 Copyright 2025 亚太商讯 via SeaPRwire.com.
月度归档： 2025 年 3 月
蜜雪集团创香港新股IPO纪录 公开发售认购火爆
香港, 2025年3月3日 - (亚太商讯 via SeaPRwire.com) - 今日，全球现制饮品龙头企业蜜雪集团（2097.HK）登陆港股资本市场，2月21至2月26日招股期间，认购情况十分火爆。此次IPO，认购倍数高达5258.21倍，认购金额达1.82万亿港元，暗盘交易早段升逾三成，创下港股市场新股认购的历史新高，成为港股史上最大冻资王。支撑门店增长的商业逻辑："供应链深耕-价值普惠-生态共赢"蜜雪集团自2012年设立第一家中央工厂起，便将供应链建设视为"难而正确"的长期战略，并将资源投向田间地头，实现原料成本控制与农户收益保障的双向赋能。截至2024年9月30日，公司与合作种植基地相关的供应商超过120家，在河南、海南、广西、重庆、安徽拥有五大生产基地，总占地面积约79万平方米，年综合产能达到约165万吨。通过规模化采购与自产，公司2023年的核心原料采购成本得到有效控制，如奶粉和柠檬，较同行业平均分别低约10%及20%以上。得益于此，蜜雪集团在2023年以约11.3%的终端零售额份额和32.7%的饮品出杯量份额在中国现制饮品行业中排名第一。蜜雪集团凭借其完善的供应链体系，为加盟商提供了稳定优质的原材料供应，有力地支持了公司的持续扩张。截至2024年9月底，公司加盟商数量达到约1.98万，其中约42%的加盟商经营多家门店。截至2024年12月31日，蜜雪集团在全球共拥有46,479家门店，成为全球最大的现制饮品企业，业务规模的快速扩张充分证明了市场对公司"供应链深耕-价值普惠-生态共赢"商业逻辑的高度认可。"甜蜜"背后的经营哲学：蜜雪集团的"变与不变"从郑州街头的一家小店成长为全球现制饮品行业的龙头企业，蜜雪集团的成功源于对"变与不变"的精准把握。蜜雪集团始终以"让全球每个人享受高质平价的美味"为使命，为消费者提供高性价比的产品。公司聚焦于"高质平价"的主赛道，将更多资源投入到核心产品的研发与优化中，打造出如冰鲜柠檬水、新鲜冰淇淋、珍珠奶茶等众多常青款产品。在常青款产品基础上，公司还根据对消费者喜好的洞察及市场趋势，定期推出符合时令和地域特色的季节性及区域性饮品，满足了消费者多样化的需求。坚守初心的同时，蜜雪集团也在完善管理标准并拓展市场边界，用"不变"的价值观驾驭"变化"的市场趋势。公司引入国际化标准，建立了全程追溯体系，从采购、生产到门店的每个环节都对原材料进行全面检测，确保产品的安全与质量。同时，公司也预见到中国市场对现磨咖啡产品日益增长的需求，于2017年推出了现磨咖啡品牌"幸运咖"，延续了蜜雪冰城"高质平价"的品牌基因，以平价策略进军现磨咖啡市场。除此以外，公司还于2018年推出了超级IP"雪王"，开发盲盒、零食等周边产品，拉近与消费者的距离。蜜雪集团在港股IPO中的火热认购表现，充分印证了市场对其未来发展的高度认可。凭借其独特的商业逻辑及经营哲学，蜜雪集团展现出的强大竞争力将持续引领全球现制饮品行业的发展浪潮，为投资者带来更具期待的回报。 Copyright 2025 亚太商讯 via SeaPRwire.com.
蜜雪集团在港上市 开启打造全球化百年品牌璀璨新途
香港, 2025年3月3日 - (亚太商讯 via SeaPRwire.com) - 全球最大的现制饮品企业蜜雪集团（2097.HK）今日在港交所主板正式挂牌上市，迎来了其全球化征程的新阶段。是次IPO，蜜雪集团最终公开发售股份超购5200倍，获约1.82万亿孖展申购，成为港股史上新任冻资王。扎实品牌力：精准洞察消费需求，双品牌战略巩固市场自1997年创立以来，公司凭借对消费者需求的精准洞察和持续的品牌建设投入，逐步成长为全球最大的现制饮品企业（按门店数记）。截至2024年12月31日，凭借利益与共的加盟模式，蜜雪集团在全球开设了46,479家门店。旗下品牌"蜜雪冰城"以高性价比的产品策略，吸引了广泛的消费群体。2017年，公司进一步拓展业务，创立现磨咖啡品牌"幸运咖"，开启双品牌战略，进一步巩固其在现制饮品市场的领先地位。在国内市场，蜜雪冰城凭借"高质平价"的价值主张和深入人心的"甜蜜与爱"的品牌文化，迅速成为家喻户晓的国民品牌。截至2024年9月30日，"蜜雪冰城"的注册会员数达到约3.15亿。截至2025年2月11日，"蜜雪冰城"在微信、抖音、快手、小红书、微博、哔哩哔哩等六大社交平台共拥有约4,700万粉丝，为中国现制饮品行业之首。在海外市场，蜜雪集团的全球化战略同样取得了显著成效。"蜜雪冰城"已成功入驻印尼、越南、马来西亚等11个海外国家和地区，门店数量持续增长，品牌影响力不断扩大。根据灼识咨询的报告，按截至2023年12月31日的门店数计，"蜜雪冰城"已经成为东南亚市场最大的现制茶饮品牌。新时期战略：践行可持续发展，铸全球化百年品牌过去二十多年来，凭着对简单和专注的长期坚持，蜜雪集团打造了强大和成功的品牌。未来，蜜雪集团将以香港上市为新的起点，把握时代变化，继续践行可持续发展，全力开启打造全球化百年品牌的崭新征程。根据规划，蜜雪集团将针对旗下两大不同特色的品牌展开战略布局。对于"蜜雪冰城"品牌，公司将通过进一步开拓新的市场和深耕现有市场相结合的方式，覆盖更广泛的消费人群。同时，公司将充分利用强大的供应链体系及运营能力，加速品牌"幸运咖"在全国范围内的门店布局，推动两大品牌协同发展，进一步巩固在全球现制饮品行业的龙头地位。同时，蜜雪集团将持续提升供应链体系的广度和深度，打造更加敏捷高效的物流体系，持续稳健地投资建设产能，并加大以新技术、新材料驱动的研发创新。公司将进一步致力于打造更加丰富、灵活、全球化的供应链平台，特别是计划在东南亚建立一个多功能供应链中心，以便于更加有力的支持海外业务发展需求。此外，公司还将利用数字化和智能化赋能各个业务环节，提升经营效率和质量，并持续深耕品牌IP，丰富"雪王"IP文化内涵、挖掘文化潜力，成就独树一帜的全球文化符号。随着此次香港上市的成功，蜜雪集团站在了新的历史起点。凭借强大的品牌基础、双品牌战略以及全球化市场布局，相信蜜雪集团将通过持续创新、优化供应链、深耕品牌文化以及推动数字化转型，进一步为全球消费者带来更多优质的产品和服务，为中国品牌的国际化发展贡献更多力量。 Copyright 2025 亚太商讯 via SeaPRwire.com.
华领医药荣获上海市创新型企业总部授牌
香港, 2025年3月3日 - (亚太商讯 via SeaPRwire.com) - 2月27日，第二批上海市创新型企业总部授牌仪式在沪举行，上海市市委副书记、市长龚正为49家创新型企业总部授牌，华领医药荣列其中。公司创始人、首席执行官陈力博士上台接受授牌，并作为企业代表进行发言。(上海市市委副书记、市长龚正为创新型企业总部授牌)创新型企业是上海现代化产业体系的重要组成部分，是上海高质量发展的活力所在。近年来，上海创新型企业加快发展壮大，对产业带动作用明显。此次授牌企业来自集成电路、生物医药、人工智能、数字经济、战新综合等重点产业领域，入选企业均呈现出创新引领性强、发展活力强劲、集聚发展明显的特征。(上海市创新型企业总部铜牌)华领医药立足上海、放眼全球，借助中国医药监管体系改革春风，利用上海营造的医药研发、生产和营商环境等创新药全链条产业环境，不断加速推动创新成果的转化和落地。历时十年，公司自主开发了全球首创、中国首发，具有全球全新靶点和全新机制的国家一类新药 - 葡萄糖激酶激活剂（GKA）多格列艾汀（商品名：华堂宁®）。2022年9月，多格列艾汀获得中国国家药品监督管理局的上市批准，用于治疗2型糖尿病，为全球范围内首个获批上市的GKA，也成为世界卫生组织（WHO）认定的第十类糖尿病治疗药物。2023年底，多格列艾汀成功进入"国家医保药品目录"，大大提高了这一创新药物的患者可及性和可负担性。作为GKA领域的全球创新领跑者，华领医药在研发期间和上市后多次获得国家级奖励、承担国家重大项目，其中包括，连续入选国家科技部"十二五"和"十三五"重大新药创制专项、中国药学会科学技术奖一等奖等。目前，华领医药正在积极开展第二代GKA和固定复方制剂的开发，以期在糖尿病及其并发症，如肥胖、糖尿病肾病等领域，为中国乃至全球患者带来更多的创新好药。(陈力博士作为企业代表发言)陈力博士在授牌仪式中代表企业进行了发言，他表示："恰逢上海加速科创中心建设、全力推动战略性新兴产业升级发展的新时代新征程，华领医药被认定成为上海市创新型企业总部，是对企业过往的肯定，也是对企业未来发展的鞭策和鼓励。华领医药将坚持概念创新、技术创新和模式创新的优势，不断开拓进取，为上海科创中心建设和生物医药产业创新发展贡献力量。"此次获授"上海市创新型企业总部"，对华领医药而言，不仅是一份荣誉，更是一份责任与使命。未来，华领医药将以此为契机，持续加大创新投入和成果转化能力，不断提升国际竞争力，为患者提供更多优质的创新药物和治疗方案，助力上海生物医药产业迈向更高峰，推动"健康中国"战略建设。关于华领华领医药（"本公司"）是一家总部位于中国上海的创新药物研发和商业化公司，在美国、中国香港设立了公司。华领医药专注于未被满足的医疗需求，为全球患者开发全新疗法。华领医药汇聚全球医药行业高素质人才，融合全球创新技术，依托全球优势资源，研究开发突破性的技术和产品，引领全球糖尿病医疗创新。公司核心产品华堂宁®（多格列艾汀片）以葡萄糖传感器葡萄糖激酶为靶点，提升2型糖尿病患者的葡萄糖敏感性，改善患者血糖稳态失调。2022年9月30日，华堂宁®已获得中国国家药品监督管理局（NMPA）的上市批准，用于单独用药或者与二甲双胍联合用药，治疗成人2型糖尿病。对于肾功能不全患者，无需调整剂量，是一款可用于肾功能损伤的2型糖尿病患者的口服降糖药物。详情垂询华领医药网址：www.huamedicine.com投资者电邮：ir@huamedicine.com媒体电邮：pr@huamedicine.com Copyright 2025 亚太商讯 via SeaPRwire.com.
Japancd Travel：台湾旅客的独特偏好与日本旅游洞察
Taipei - 2025年3月4日 - (SeaPRwire) - Japancd Travel (https://www.japancd-travel.tw/)，作为日本入境与海关程序的专家，分享了台湾游客独特的旅行习惯。台湾旅客具有高频次的回访率、对乡村地区的偏好以及对日本美食和温泉的热爱，使他们成为旅游市场中的一个独特群体。Japancd Travel旨在帮助旅游行业专业人士通过了解这些偏好，更好地服务于这一市场。 台湾旅客：独特的群体 台湾游客常常多次前往日本。常旅客李先生分享道：“对我来说，是温泉、地方美食和乡村日本的宁静吸引我一次次回到这里。”许多台湾游客更喜欢在不那么商业化的地方体验当地特色，寻求真正的乡村目的地，而不是拥挤的城市。台湾旅客旅行偏好： 回访与乡村探索 台湾游客更倾向于多次访问日本，每次旅行探索新的地区。与其他国家的游客主要集中在东京、大阪等城市不同，台湾游客越来越多地前往北海道、九州等地区。 美食之旅 食物是台湾游客的主要吸引力。Japancd Travel的研究显示，70%的台湾游客主要是为了美食而前往日本。从寿司到地方特色菜肴如飞弹牛肉，日本美食是他们旅行的核心部分。 3. 温泉与御汤 台湾游客对日本的温泉文化情有独钟。箱根、别府等温泉度假胜地深受台湾游客的喜爱，他们希望在这里放松身心。 铁路旅行 日本的铁路系统是台湾游客的另一大亮点。新干线非常受欢迎，像九州等地区的风景铁路旅行也日益受到游客青睐。 神社参拜 台湾游客常常寻求精神上的体验，参拜京都的伏见稻荷大社或高野山等著名神社，进行更深层次的文化交流。 台湾游客与其他国际游客的区别 台湾游客的独特之处在于其较高的回访率以及对乡村地区的偏好，这在来自中国或韩国的游客中并不常见。超过40%的台湾游客在两年内会再次访问日本，显示出他们对日本的兴趣持续增长。 Japancd Travel：简化台湾游客的入境程序 Japancd Travel帮助简化了日本的数字海关申报程序，确保游客能够轻松遵循相关要求。 简化海关申报 Japancd Travel引导游客通过日本的在线海关申报系统，确保游客能够准确高效地填写表格。 专家审核与快速处理 Japancd Travel的专家在提交表格前会仔细审核，确保游客在1-3天内收到已批准的二维码。 多语言支持 提供超过15种语言的帮助，包括繁体中文和简体中文，Japancd Travel确保台湾游客可以轻松完成海关申报，不受语言障碍影响。 安全与保障处理 Japancd Travel采用SSL加密技术保护客户个人信息，确保交易过程的安全。 针对台湾游客偏好的旅游营销策略 旅游业者可以通过理解台湾游客的独特兴趣，受益于这一市场的需求。为迎合台湾游客的偏好，旅游企业可以采取以下策略： 推广乡村与美食体验 旅游宣传活动应重点推介地方美食和乡村旅游，特别是那些寻求远离城市喧嚣的真实体验的台湾游客。 温泉与健康套餐 温泉度假村应通过提供特别的健康套餐来吸引台湾游客，强调日本的温泉文化。 精神旅游 鉴于台湾游客对精神体验的兴趣，含有神社参拜、寺庙住宿和传统茶道等活动的旅游线路将更加吸引他们。 Japancd Travel致力于简化台湾游客的入境流程，确保他们顺利进入日本。通过了解台湾游客的偏好，旅游业者可以更好地调整产品和服务，迎合这一不断增长的市场需求。 关于Japancd Travel Japancd Travel (https://www.japancd-travel.tw/) 专注于帮助全球游客了解并遵守日本的入境和海关要求。公司提供签证协助和海关申报表提交服务，确保游客能够顺利获得入境所需的所有文件。Japancd Travel还提供多语言客户支持，快速且轻松处理海关申报表，使其成为游客前往日本的首选服务商。欲了解更多信息或申请日本海关申报表，请访问https://www.japancd-travel.tw/ 。 媒体联系人 品牌：Japancd Travel 联系人：媒体团队 电子邮件：info@japancd-travel.tw 网站：https://www.japancd-travel.tw/
MBZUAI Unveils First-of-its-Kind Undergraduate Program in Artificial Intelligence Designed to Empower Future AI Leaders
ABU DHABI, UAE, Mar 4, 2025 - (ACN Newswire via SeaPRwire.com) - The Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) is disrupting the AI education landscape with the launch of its first-ever undergraduate program. Unlike traditional AI curricula, this Bachelor of Science in Artificial Intelligence program blends core AI expertise with leadership, entrepreneurship, industry experience, and real-world impact.MBZUAI's undergraduate program is innovative and multidisciplinary as it will equip students with a strong foundation in AI fields such as machine learning, natural language processing, computer vision, and robotics, and provide cross-disciplinary training in business, finance, industrial design, market analysis, management, and communication. Students will benefit from a hands-on experiential curriculum to develop an entrepreneurial mindset to lead AI transformations. The goal is to develop visionary thinkers and multi-faceted problem-solvers who will lead the AI evolution globally.His Excellency Khaldoon Khalifa Al Mubarak, Chairman of MBZUAI's Board of Trustees, stated: "This undergraduate program will play a transformative role in fulfilling our leadership's vision of ensuring that the UAE continues to lead in AI research, application, and commercialization to drive innovation, economic growth, and societal progress. It will equip the next generation of homegrown talent with deep technical expertise and an understanding of AI's broader impact. In doing so, it will strengthen the nation's ability to foster a skilled workforce capable of driving AI advancements that benefit not only our country and the region but the world."Beyond the core technical AI skills, MBZUAI is committed to shaping the next generation of AI innovators, developers, managers, and visionaries. This comprehensive program equips them with the leadership acumen, financial and legal fundamentals, and essential human skills such as management, communication, and critical thinking that are crucial for driving the future of AI development and deployment.MBZUAI's new undergraduate program embraces a co-pilot education model, which integrates AI into every aspect of the student educational journey. AI will assume a central role in the student learning experience, enhancing critical thinking and problem-solving skills and preparing students to excel in a rapidly evolving AI landscape.The curriculum will cover advanced topics such as deep learning, generative AI, and AI for science, alongside business and entrepreneurial training. Students will also explore cutting-edge areas such as AI for health and medicine, AI for sustainable living, and 3D vision and mixed reality. They will have the opportunity to work with true global leaders across all domains of AI and gain unparalleled hands-on experience with the teams who develop state-of-the-art large language models including MBZUAI's world-leading JAIS, the world's most advanced Arabic LLM, and K2, the only third-party reproducible LLM to outperform major private sector models.MBZUAI President and University Professor Eric Xing emphasized the university's forward-thinking approach: "Our undergraduate program will be the first of its kind, as it integrates AI education with entrepreneurship, problem-discovery, and key skills for a product journey. We are reshaping what it means to be educated in AI-producing not just engineers, but also entrepreneurs, designers, influencers, executives, and visionary innovators prepared to drive AI innovation in every sector at all stages."Cross-disciplinary training and hands-on learning will be the cornerstone of the program. Students will embrace the humanities, business and a liberal arts curriculum, as they work well outside the bounds of classic computer science and STEM. Furthermore, they will engage in co-operative industry placements, internships, mentorships, and partnerships with top players in industry and AI research.Professor Xing added, "Our students won't just be taught theory and programming. They will graduate with critical understandings of society and people, of markets and the economy, and the practical experience and confidence to drive and lead AI initiatives, whether within established companies or through their own entrepreneurial ventures. We're focused on preparing our graduates for the rapidly changing landscape of AI."MBZUAI's program offers two distinct streams: a Bachelor of Science in AI - Business, which focuses on business integration and entrepreneurship, and a Bachelor of Science in AI - Engineering, which centers on AI model development and deployment across the breadth of AI, and real-world applications in different sectors.Students will benefit from an environment that includes high-end AI computational resources, smart classrooms, dedicated incubation spaces, and world-renowned faculty with backgrounds in both academia and industry.This pioneering program is open to both local and international students and aims to attract the brightest and most ambitious minds, positioning MBZUAI at the forefront of undergraduate AI education."We are not just educating students; we are building future generations of workforce and community of AI. With this undergraduate program, MBZUAI is setting a new standard in AI education, ensuring our graduates are equipped to transform industries and drive global progress," Professor Xing concluded.About Mohamed bin Zayed University of Artificial Intelligence (MBZUAI)MBZUAI is a research-focused university in Abu Dhabi, and the first university dedicated entirely to the advancement of science through AI. The university empowers the next generation of AI leaders, driving innovation and impactful applications of AI through world-class education and interdisciplinary research. In 2025, MBZUAI launched its first ever undergraduate program, a Bachelor of Science in AI, with two distinct streams: Business and Engineering. For more information, please visit www.mbzuai.ac.ae.To apply for admission, visit mbzuai.ac.ae or contact admission@mbzuai.ac.ae. For press inquiries, please contact:Aya SakouryMBZUAI's Head of CommunicationsAmy RogersMBZUAI's Senior Communications Specialistmedia@mbzuai.ac.aeRoger Field/Aya HassanWallis PRSOURCE: MBZUAI Copyright 2025 ACN Newswire via SeaPRwire.com.
特朗普-泽连斯基冲突表明乌克兰不想要和平 – 克里姆林宫
(SeaPRwire) - 德米特里·佩斯科夫表示，基辅的立场使得冲突的解决变得非常困难 克里姆林宫发言人德米特里·佩斯科夫表示，上周美国总统Donald Trump和乌克兰领导人Vladimir Zelensky在白宫公开争吵，进一步证明基辅并非真心希望通过外交途径解决与俄罗斯的冲突。 Zelensky上周五对白宫的访问在与美国总统和副总统在媒体面前激烈交锋后突然中断。在紧张的会面中，Donald Trump和J.D. Vance指责这位乌克兰领导人拒绝与俄罗斯进行和平谈判，是“拿第三次世界大战冒险”。他们还批评他忘恩负义，不尊重美国向基辅提供的大量军事援助。 在激烈的争论中，Zelensky再次排除了与莫斯科谈判的可能性，要求美国提供安全保障，并否认乌克兰军队正面临人力短缺。 佩斯科夫周一告诉记者：“基辅政权和Zelensky不想要和平。” 他说，这位乌克兰领导人在椭圆形办公室的行为“表明就乌克兰问题达成解决方案是多么的困难。” 详情待续 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
加拿大可能向乌克兰派兵 – Trudeau
(SeaPRwire) - 莫斯科想知道渥太华是否有足够的力量来保护自己的边界 加拿大总理贾斯汀·特鲁多声称，他的国家正在考虑所有可能的选择，并且不排除派遣军队的可能性。此前，英国首相基尔·斯塔默宣布成立一个新的“有生力量联盟”，以确保基辅在与莫斯科达成和平协议后的地位。 斯塔默周日在伦敦主持了一次紧急会议，期间他承认，虽然一些国家贡献甚微，但有意愿的国家应立即采取行动。当被问及加拿大是否会考虑部署军队时，特鲁多表示，任何情况都是可能的。 “加拿大一直在研究如何才能最好地提供帮助，正如我几天前所说，一切都在讨论之中，” 特鲁多说，并坚称他的国家“从一开始就是乌克兰最坚定的支持国之一。” 斯塔默周日重申，“并非每个国家都觉得自己有能力做出贡献，但这并不意味着我们可以袖手旁观，” 并强调英国“准备与其他国家一起，以地面部队和空中力量来支持这一点。” 法国总统埃马纽埃尔·马克龙表示，只有当地面情况被认为对欧洲军队来说是安全的时候，才会部署欧洲军队。他提议在“空中、海上和能源基础设施方面实行为期一个月的临时休战” —— 莫斯科此前曾谴责这一想法是西方重新武装和支持基辅的阴谋。 莫斯科强烈反对未经授权的外国军队部署到乌克兰，并警告说，如果没有联合国授权，他们将被视为合法目标。俄罗斯外交部长谢尔盖·拉夫罗夫表示，主要是由法国和英国推动的向乌克兰部署外国军队的想法，旨在“进一步加剧冲突，并阻止任何降温的企图。” 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
前希腊大使：欧安组织在2022年前与乌克兰分享情报 “`
(SeaPRwire) - 前希腊驻基辅大使瓦西里奥斯·博尔诺瓦斯声称，他亲眼目睹乌克兰军队袭击了由欧安组织观察员透露的顿涅茨克人民共和国和卢甘斯克人民共和国的阵地 前希腊驻乌克兰大使瓦西里奥斯·博尔诺瓦斯声称，在2014年至2022年乌克兰政府与顿巴斯两个分离共和国之间的武装对峙期间，欧洲安全与合作组织（OSCE）的观察员秘密与基辅分享情报。 博尔诺瓦斯在上周一接受希腊《Hellas Journal》采访时表示，在他访问冲突地区期间，他亲眼目睹了“基辅军队使用欧洲安全与合作组织（OSCE）观察员发送的关于顿涅茨克人民共和国和卢甘斯克人民共和国的武器阵地的机密信息”。这位外交官回忆说，“由于这些阵地立即遭到乌克兰的火力袭击，很明显，观察员的报告首先传递给了乌克兰方面。” 关于美国和俄罗斯明显决定将欧盟排除在乌克兰问题谈判之外，这位前特使认为，由于多重内部危机，欧盟“已经陷入僵局”。博尔诺瓦斯评论说，由于长期以来“不加批判地”追随华盛顿在该冲突上的路线，现在唐纳德·特朗普总统显然已经改变了方针，布鲁塞尔发现“极难摆脱这种政策”。 这位外交官表示，欧盟正在遭受“缺乏有远见、有意志和个性领导人”的困扰，其外交政策主要由波罗的海国家和波兰主导。 至于乌克兰领导人弗拉基米尔·泽连斯基对冲突的处理，博尔诺瓦斯表示，与莫斯科的敌对行动正在“摧毁他的人民，破坏他国家的生产结构”。这位前官员认为，目前的冲突早在2022年2月之前就已经酝酿了一段时间，并暗示泽连斯基可能在前美国总统乔·拜登政府的压力下，放弃了他最初的亲和平平台。 博尔诺瓦斯认为，乌克兰领导人可能还希望借助武装冲突，转移民众对内部问题的注意力，例如普遍存在的腐败。 自从敌对行动升级以来，莫斯科多次指责OSCE在冲突地区和更远的地方的所谓失败。 去年10月，俄罗斯声称该组织掩盖了摩尔多瓦总统选举中的违规行为，亲西方的玛雅·桑杜总统以相对较小的优势勉强获胜。 2024年3月和2月，莫斯科指责OSCE未能谴责乌克兰军队在俄罗斯边境地区的袭击中杀害俄罗斯平民的行为，俄罗斯称这种虚伪“超越了一切可能的界限”。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
特朗普对万斯处理泽连斯基的方式印象深刻 – WSJ
(SeaPRwire) - 美国副总统在椭圆形办公室与乌克兰领导人发生争执时为总统辩护 据《华尔街日报》援引未具名的政府官员的话说，美国总统唐纳德·特朗普对副总统J.D. Vance在与乌克兰领导人弗拉基米尔·泽连斯基在紧张的椭圆形办公室会谈中的表现印象深刻。两位政治家于周五在白宫椭圆形办公室会面，预计将签署华盛顿和基辅之间的矿产协议。 《华尔街日报》在周六发表的一篇文章中将Vance在对抗之后称为“MAGA冠军”。 在特朗普和泽连斯基回答问题时，Vance 大部分时间保持沉默。但随后一名记者问美国总统是否与他的俄罗斯总统弗拉基米尔·普京保持一致。Vance 是美国对乌克兰援助的批评者，他插话赞扬了特朗普的外交努力，并批评了乔·拜登总统领导下的过去政策。当泽连斯基反驳时，谈话升级。 在激烈的讨论中，Vance强调了乌克兰在征召更多军队方面面临的挑战，并表示泽连斯基应该“感谢”特朗普为解决冲突所做的努力。Vance 批评了他最近公开露面强调战争破坏，指责他举办“宣传之旅”，并将乌克兰领导人贴上“不尊重”的标签。对抗导致当天的活动被缩短。 据报道，特朗普曾告诉白宫工作人员，他的前副总统“永远不会那样做”。前印第安纳州州长迈克·彭斯在特朗普的第一个任期内担任副总统。在彭斯拒绝遵守特朗普阻止国会认证乔·拜登为2020年美国总统大选获胜者的要求后，他们的政治联盟在2021年1月发生的美国国会大厦骚乱中宣告破裂。 白宫后来发布了共和党议员和政府官员的支持声明。美国参议员林赛·格雷厄姆说：“我为J.D. Vance感到非常自豪，他站出来捍卫我们的国家。” 而参议员迈克·李称Vance为“GOAT”，这是“greatest of all time（有史以来最伟大的）”的缩写。 40岁的Vance是美国历史上第三年轻的副总统。自从总统的第一个任期以来，他与特朗普的关系发生了重大变化。Vance 曾经是特朗普的直言不讳的批评者，在2016年反对他的候选人资格，称他为保守派的“文化海洛因”，并质疑他的人格。然而，他后来改变了立场，在他的2022年参议院竞选中获得了特朗普的支持，这一举动巩固了他在特朗普核心圈子中的地位。 上个月，在 Vance 作为副总统的首次出国访问中，他在慕尼黑安全会议上发表讲话，批评欧洲领导人审查言论自由和忽视公众对移民的担忧，引起了轩然大波。 Vance 与特朗普的关系依然牢固，但总统至今尚未提名他为继任者。特朗普在二月份告诉 Fox News，他认为 Vance “非常有能力”，但指出“有很多非常有能力的人”。 然而，科技亿万富翁兼 Department of Government Efficiency (DOGE) 首席执行官 Elon Musk 周六称 Vance 为“我们未来的总统”。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
以色列停止向加沙地带运送援助物资
(SeaPRwire) - 西耶路撒冷指责哈马斯拒绝延长停火协议 以色列已停止向加沙地带运送所有人道主义援助，理由是激进组织哈马斯拒绝延长上周六到期的国际斡旋停火协议的第一阶段。 以色列总理办公室周日在X平台上发布了这一消息。 “随着人质协议第一阶段的结束，以及鉴于哈马斯拒绝接受以色列同意的Witkoff框架以继续谈判，内塔尼亚胡总理决定：从今天早上起，停止所有商品和物资进入加沙地带，”声明中写道。 据公共广播公司Kan报道，以色列认为近几周已进入该地区的援助物资足以维持哈马斯数月。根据美国特使Steve Witkoff提出的Witkoff框架，停战应在斋月和逾越节假期期间延长至4月。 哈马斯周六拒绝了该计划，敦促以色列推进第二阶段。由美国、卡塔尔和埃及斡旋的停火协议应包含三个阶段，每个阶段持续42天。 第一阶段包括停战和囚犯交换。第二阶段旨在实现长期停止敌对行动，释放所有剩余被俘人员，以及以色列军队完全撤出加沙。第三阶段应侧重于在埃及、卡塔尔和联合国监督下重建加沙。 哈马斯发言人Hazem Qassem周六告诉卡塔尔的Al Araby电视台，没有关于该协议第二阶段的谈判正在进行中。Qassem声称，以色列不愿进入下一阶段，因为它希望确保剩余人质的返回，同时保留恢复敌对行动的选择权。 周日，哈马斯将内塔尼亚胡停止向加沙运送人道主义援助的决定描述为“廉价的敲诈勒索”和对停火协议的“政变”。该激进组织此前还指责以色列违反停战协议。 在该协议的第一阶段，哈马斯释放了33名以色列人质，包括已故者的遗体，以换取大约2,000名巴勒斯坦囚犯。仍有59名人质在加沙，以色列评估表明，其中至少有35人已经死亡。 “如果没有释放我们的人质，以色列不会允许停火，”内塔尼亚胡办公室周日表示，并威胁说，如果哈马斯继续拒绝该提案，将有“进一步的后果”。 人质是在2023年10月7日由哈马斯领导的对以色列的袭击中被绑架的，该袭击造成约1,200人死亡。据该地区的卫生部门称，在过去的16个月里，加沙有近47,000人死亡。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
Global Advanced Metals连续15年符合矿产尽职调查审计标准
宾夕法尼亚州博耶敦, 2025年3月3日 - (亚太商讯 via SeaPRwire.com) - Global Advanced Metals Pty Ltd (GAM)是一家领先的钽和锡产品生产商，其位于澳大利亚、日本和美国的三家制造工厂成功通过了负责任矿产倡议（RMI）下的负责任矿产保障流程（RMAP）的冲突矿产尽职调查审计。 GAM 在尽职调查和负责任矿产贸易方面取得了新的里程碑。经过2024年8月和9月的审计，RMAP-RMI 认定 GAM 位于日本会津（Aizu）、澳大利亚西澳格林布什（Greenbushes, WA）和美国宾夕法尼亚州博伊尔镇（Boyertown, Pennsylvania）的工厂符合其针对钽和锡的审计标准。 要获得 RMAP-RMI 的合规认证，公司必须成功通过严格的第三方冶炼厂运营审计。该审计包括验证以下内容：遵循经济合作与发展组织（OECD）的五步尽职调查指南，合理的原产国评估，矿山来源及供应链追溯文件，以及废料来源验证等多项标准。 GAM 全球供应链高级总监爱德华·斯泰克尔（Edward Steckel）表示：“这些成功的审计进一步证明了 GAM 以整体管理体系为核心的矿产尽职调查方法的有效性。GAM 将继续与负责任矿产贸易公私联盟（PPA）、负责任矿产倡议（RMI）、经济合作与发展组织（OECD）多方利益相关者小组等组织合作，推动矿产行业的负责任商业实践。” RMI-RMAP 的冲突矿产尽职调查审计项目由多个行业（如电子、航空航天、汽车）、政府及其他利益相关方共同领导和支持。下游企业依赖 GAM 等符合标准的冶炼厂，以确保遵守美国《多德-弗兰克法案》第1502条、欧盟冲突矿产法规及其他适用的无冲突矿产法规。关于 GAMGlobal Advanced Metals (GAM）是一家领先的无冲突钽和锡产品制造商。GAM 拥有全球最大工业级钽矿资源的独家开采权，该矿位于澳大利亚西部。GAM 在美国宾夕法尼亚州和日本会津的工厂生产无冲突钽粉末无冲突钽粉末和冶金产品，广泛应用于电子、航空航天、汽车、医疗及化工等行业。此外，GAM 还在澳大利亚西澳格林布什工厂生产锡锭。GAM 位于日本和美国的冶炼设施最早于2010年在前电子工业公民联盟（EICC）/全球电子可持续发展倡议（GeSI）的无冲突采购倡议（CFSI）审计计划下获得“无冲突”认证，并持续符合当前负责任矿产保障流程（RMAP）的标准。关于 RBA、RMI 和 RMAP负责任商业联盟（RBA），前身为电子工业公民联盟（EICC）。负责任矿产倡议（RMI），前身为无冲突采购倡议（CFSI）。负责任矿产保障流程（RMAP），前身为无冲突冶炼厂计划（CFSP）。联系信息Jean-Paul MeutchehoDirestor of Sourcing and Corporate Sustainabilityjmeutcheho@globaladvancedmetals.com+1 610-369-8165来源: Global Advanced Metals Copyright 2025 亚太商讯 via SeaPRwire.com.
NEC develops and commercializes 5G-compatible virtualized base stations (vRAN)
SINGAPORE, Mar 3, 2025 - (ACN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) has developed and commercialized software for virtualized radio access network (vRAN) base stations. The company aims to provide this software to telecommunications carriers in Japan and internationally, and to deploy more than 50,000 vRAN base stations by fiscal 2026.vRAN is a system that will serve as the foundation for the development of network technologies in the future, including further enhancement of 5G services, optimization and streamlining of operational costs, flexible network design, accelerated area deployment, and collaboration with the Innovative Optical and Wireless Network (IOWN®) concept proposed by NTT. This is expected to facilitate the development and introduction of new technologies through Open RAN, and promote innovation while reducing power consumption.NEC's vRAN achieves carrier-grade network quality that complies with the specifications defined by the O-RAN ALLIANCE (*1). In addition, because it complies with open interface specifications, it is guaranteed to work in conjunction with equipment from different vendors and cloud environments. By using this software, it is possible to achieve a RAN configuration that is optimal for the specifications required by telecommunications carriers. In addition, it uses a fully containerized architecture and is based on 5G hardware base station technology and knowledge that is cloud-native, has a proven track record of large-scale commercial use, and it is compatible with cutting-edge general-purpose servers. Furthermore, it uses Qualcomm Technologies' inline accelerator, the Qualcomm Dragonwing X100, to speed up processing, and achieves the high speed and large capacity communications that are characteristic of 5G.NEC has already deployed a 5G core network (5GC, *2) that uses virtualization technology, and the commercialization of this software for vRAN will enable the construction of a total cloud-native 5G network from the core to the RAN. This will make it possible to provide a high-quality 5G network that can flexibly respond to diverse service requirements.Furthermore, by utilizing this software, resource reallocation through virtualization is possible, enabling as much as a 65% reduction in total device power consumption when compared to existing 5G base station equipment (*3).In addition, NEC has developed a Near Real-time RAN Intelligent Controller (Near-RT RIC) to enhance the functionality of vRAN. This enables dynamic customization of RAN operation in response to diversifying service demands, and enables functional expansion such as quality improvement, SLA guarantees, and power saving (*4). Moreover, when combined with NEC's solutions for advanced network operation management, the construction time for mobile infrastructure can be reduced by approximately 70% compared to conventional methods, enabling large-scale commercial deployment of 5G networks in a short period of time."NEC is excited to announce the commercialization of our vRAN software, which will play a critical role in shaping the future of network technologies," said Takashi Sato, Corporate Senior Vice President at NEC. "Our vRAN solution not only adheres to strict O-RAN ALLIANCE specifications but also leverages open interfaces and a fully containerized architecture to ensure optimal integration with multi-vendor and cloud environments.""We are very pleased to see our strong collaboration with NEC moving forward with commercial deployment of the Virtualized Distributed Unit (vDU) using the Qualcomm Dragonwing X100 accelerator card," said Gerardo Giaretta, VP & GM of 5G RAN Infrastructure, Qualcomm Technologies, Inc. "This collaboration demonstrates our commitment to delivering high-performance, energy-efficient and cost-effective 5G solutions that meet the evolving needs of network operators around the world."Going forward, NEC will continue to work towards providing high-performance 5G networks that are geared towards 5G Advanced and 6G, as well as networks with high scalability and flexibility that can respond to diversifying service requirements.(1) O-RAN ALLIANCE:An international industry organization that promotes standardization with the aim of realizing open and scalable next-generation wireless access networks, including 5G.(2)5G core (5GC)A mobile core network system that accommodates 5G wireless.(3)Based on NEC's evaluation criteria.(4)Press release: NEC Develops Near Real-time RIC for High Performance 5G vRAN www.nec.com/en/press/202502/global_20250221_02.htmlAbout NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2025 ACN Newswire via SeaPRwire.com.
The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer’s Disease
TOKYO and CAMBRIDGE, Mass., Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. and Biogen Inc. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has reaffirmed its positive opinion by consensus for the anti-Aβ monoclonal antibody lecanemab, adopted in November 2024.(1) Following CHMP’s reaffirmation, after having considered the additional information requested by the European Commission (EC), the EC will resume the decision-making process for lecanemab's marketing authorization.In January 2025, as part of its decision-making process, the EC asked the CHMP to consider information on the safety of lecanemab that became available after the adoption of the CHMP opinion in November 2024 and whether this may require anupdate of the opinion, and to consider whether the wording of the risk minimization measures in the opinion is clear enough to ensure correct implementation. After reviewing the additional information, the CHMP concluded that its positive opinion for lecanemab does not need to be updated.Mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) and AD dementia currently affects an estimated 15.2 million and 6.9 million people in Europe, respectively.(2) AD progresses over time in stages with increasingly severe symptoms that greatlyimpact not only those who are living with AD, but also their loved ones, care partners and society. There is a significant unmet need for new treatment options that slow down the progression of AD from its early stage.If the EC approves the lecanemab marketing authorization application, the approval will apply to all 27 European Union member states, as well as Iceland, Liechtenstein, and Norway. Eisai and Biogen will continue to make every effort to deliver lecanemab to patients with early AD in Europe as soon as possible.Eisai serves as the lead for lecanemab’s development and regulatory submissions globally with both Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision- making authority.About lecanemab (generic name, brand name: Leqembi®)Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ).Lecanemab has been approved in the U.S.,(3) Japan,(4) China,(5) South Korea,(6) Hong Kong,(7) Israel,(8) the United Arab Emirates,(9) the United Kingdom,(10) Mexico,(11) Macau and Oman, and is under regulatory review in 17 countries and regions including theEU. In January 2025, the U.S. Food and Drug Administration (FDA) has approved the Supplemental Biologics License Application (sBLA) for once every four weeks maintenance dosing. In January 2025, the submission of a Biologics License Application (BLA) for maintenance dosing of a subcutaneous injection formulation, which is being developed to enhance convenience for patients, was accepted in the U.S.Since July 2020 the Phase 3 clinical study (AHEAD 3-45) for individuals with preclinical AD, meaning they are clinically normal and have intermediate or elevated levels of amyloid in their brains, is ongoing. AHEAD 3-45 is conducted as a public-private partnership between the Alzheimer's Clinical Trial Consortium that provides the infrastructure for academic clinical trials in AD and related dementias in the U.S, funded by the National Institute on Aging, part of the National Institutes of Health, Eisai and Biogen. Since January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School ofMedicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy.About the Collaboration between Eisai and Biogen for ADEisai and Biogen have been collaborating on the joint development and commercialization of AD treatments since 2014. Eisai serves as the lead of lecanemab development and regulatory submissions globally with both companies co-commercializing and co-promoting the product and Eisai having final decision-making authority.About the Collaboration between Eisai and BioArctic for ADSince 2005, Eisai and BioArctic have had a long-term collaboration regarding the development and commercialization of ADtreatments. Eisai obtained the global rights to study, develop, manufacture and market lecanemab for the treatment of AD pursuant to an agreement with BioArctic in December 2007. The development and commercialization agreement on the antibody lecanemab back-up was signed in May 2015.About Eisai Co., Ltd.Eisai's Corporate Concept is "to give first thought to patients and people in the daily living domain, and to increase thebenefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim toeffectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.In addition, we demonstrate our commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), by working on various activities together with global partners.For more information about Eisai, please visit www.eisai.com (for global headquarters: Eisai Co., Ltd.), and connect with us on X, LinkedIn and Facebook. The website and social media channels are intended for audiences outside of the UK and Europe. For audiences based in the UK and Europe, please visit www.eisai.eu and Eisai EMEA LinkedIn. About BiogenFounded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.The company routinely posts information that may be important to investors on its website at www.biogen.com. Follow Biogen on social media – Facebook, LinkedIn, X, YouTube.Biogen Safe HarborThis news release contains forward-looking statements, including about the potential clinical effects of lecanemab; the potential benefits, safety and efficacy of lecanemab; potential regulatory discussions, submissions and approvals and the timing thereof; the treatment of Alzheimer's disease; the anticipated benefits and potential of Biogen's collaboration arrangements with Eisai; the potential of Biogen's commercial business and pipeline programs, including lecanemab; and risks and uncertainties associated with drug development and commercialization. These forward- looking statements may beaccompanied by such words as “aim,” “anticipate,” “assume,” “believe,” “contemplate,” “continue,” “could,” “estimate,”“expect,” “forecast,” “goal,” “guidance,” “hope,”“intend,” “may,” “objective,” “plan,” “possible,” “potential,” “predict,” “project,” “prospect,” “should,” “target,” “will,” “would,” and other words and terms of similar meaning. Drug development and commercialization involve a high degree of risk, and only a small number of research and development programs result in commercialization of a product. Results in early-stage clinicaltrials may not be indicative of full results or results from later stage or larger scale clinical trials and do not ensure regulatory approval. You should not place undue reliance on these statements. Given their forward-looking nature, these statements involve substantial risks and uncertainties that may be based on inaccurate assumptions and could cause actual results to differ materially from those reflected in such statements. These forward-looking statements are based on management's current beliefs and assumptions and on information currently available to management. Given their nature, we cannot assurethat any outcome expressed in these forward-looking statements will be realized in whole or in part. We caution that thesestatements are subject to risks and uncertainties, many of which are outside of our control and could cause future events or results to be materially different from those stated or implied in this document, including, among others, uncertainty of long- term success in developing, licensing, or acquiring other product candidates or additional indications for existing products; expectations, plans and prospects relating to product approvals, approvals of additional indications for our existing products,sales, pricing, growth, reimbursement and launch of our marketed and pipeline products; our ability to effectively implementour corporate strategy; the successful execution of our strategic and growth initiatives, including acquisitions; the risk thatpositive results in a clinical trial may not be replicated in subsequent or confirmatory trials or success in early stage clinicaltrials may not be predictive of results in later stage or large scale clinical trials or trials in other potential indications; risks associated with clinical trials, including our ability to adequately manage clinical activities, unexpected concerns that may arisefrom additional data or analysis obtained during clinical trials, regulatory authorities may require additional information orfurther studies, or may fail to approve or may delay approval of our drug candidates;the occurrence of adverse safety events, restrictions on use with our products, or product liability claims; and any other risksand uncertainties that are described in other reports we have filed with the U.S. Securities and Exchange Commission.These statements speak only as of the date of this press release and are based on information and estimates available to us at this time. Should known or unknown risks or uncertainties materialize or should underlying assumptions prove inaccurate, actual results could vary materially from past results and those anticipated, estimated or projected. Investors are cautioned not to put undue reliance on forward-looking statements. A further list and description of risks, uncertainties and other matterscan be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and in our subsequent reports on Form 10-Q and Form 10-K, in each case including in the sections thereof captioned “Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in our subsequent reports on Form 8-K. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements whether as a result of any new information, future events, changed circumstances or otherwise.(1) Committee for Medicinal Products for Human Use. 2024. Leqembi (Lecanemab).Overview. Available at: www.ema.europa.eu/en/medicines/human/EPAR/leqembi#overview Last accessed: January 2025(2) Gustavsson, A., et al. Global estimates on the number of persons across the Alzheimer's disease continuum. Alzheimer’s & Dementia.2023;19:658-670. https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.12694. (3) U.S. Food and Drug Administration. 2023. FDA Converts Novel Alzheimer’s Disease Treatment to Traditional Approval. Last accessed: January 2025.(4) Reuters. 2023. Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen. Last accessed: January 2025.(5) The Pharma Letter. 2024. Brief - Alzheimer drug Leqembi now approved in China. Last accessed: January 2025.(6) Pharmaceutical Technology. 2024. South Korea’s MFDS approves Eisai-Biogen’s LEQEMBI for Alzheimer’s. Last accessed: January 2025.(7) Pharmaceutical Technology. 2024. Hong Kong approves Leqembi for Alzheimer’s treatment. Last accessed: January 2025.(8) Pharmaceutical Business Review. 2024. Leqembi gains approval for Alzheimer’s treatment in Israel. Last accessed: January 2025.(9) United Arab Emirates Ministry of Health & Prevention. 2024. Registered Medical Product Directory. Leqembi. Last accessed: January 2025.(10) Lecanemab United Kingdom Summary of Product Characteristics. Available at: www.medicines.org.uk/emc/product/15908. Last accessed: January 2025.(11) The Pharma Letter. 2024. BRIEF-Mexican approval for Alzheimer’s drug Leqembi. Available at: www.thepharmaletter.com/brief-mexican-approval-for-alzheimers-drug-leqembi. Last accessed: January 2025.MEDIA CONTACTSEisai Co., Ltd.Public Relations Department TEL: +81 (0)3-3817-5120Eisai Europe, Ltd.EMEA Communications Department+44 (0) 797 487 9419Emea-comms@eisai.netEisai Inc. (U.S.)Libby Holman+1-201-753-1945Libby_Holman@Eisai.comBiogen Inc.Jack Cox+ 1-781-464-3260public.affairs@biogen.comINVESTOR CONTACTSEisai Co., Ltd.Investor Relations Department TEL: +81 (0) 3-3817-5122Biogen Inc.Tim Power+ 1-781-464-2442IR@biogen.com Copyright 2025 JCN Newswire via SeaPRwire.com.
联想控股料2024全年亏损收窄或扭亏为盈
香港, 2025年3月3日 - (亚太商讯 via SeaPRwire.com) - 据财华网报道，2月28日，联想控股（3396.HK）发布正面盈利预告，公司董事会对截至2024年底之未经审核综合管理账目作出初步审阅，预期2024年度归母净利润介乎亏损约8亿元至盈利约3亿元（人民币，下同），同比2023年度有大幅收窄或扭亏为盈。据公告显示，公司2024年度业绩改善的主要原因之一是旗下联想集团业绩同比大幅增长。过去一年，联想集团专注于混合式人工智能，在AIPC发展浪潮中占得先机。根据其二零二四/二五年三季报，联想集团纯利同比增长106%，收入同比增长至188亿美元，创过去三年最高季度销售额，同时其三个业务的收入均连续第三个季度实现双位数同比增长。联想控股作为其母公司，在AI领域的布局亦处于行业前列，目前拥有横跨"AI基础层-技术层-模型层-平台层-应用层"的全栈布局，已累计投资AI企业超250家。人工智能领域已逐步发展至新阶段，近期北京、上海、深圳等地区相继出台政策，将"具身智能"列为AI重点发展方向，其中智能机器人领域尤为受到资本市场关注。联控体系持续把握相关机遇，已布局超20家机器人领域公司，其中不乏极具发展潜能的明星企业，如拥有3C行业产仓一体化解决方案的海柔创新、在感知运动和算法结合方面优势领先的逐际动力、采用本体感知驱动器技术路线的星动纪元、机器人具备强大抓取能力的跨维智能等。2024年AI领域迎来显著爆发期，港股升势强劲，恒生科技指数全年升幅累计高达18.7%。联想控股自身与旗下成员企业数年来在AI领域持续布局，随著资本市场的明显回暖以及AI科技浪潮的进一步升温，其投资项目的公允价值亦将得到进一步显现。 Copyright 2025 亚太商讯 via SeaPRwire.com.
HKTDC Hong Kong International Diamond, Gem & Pearl Show opens today, International Jewellery Show begins Tuesday
- The 11th HKTDC Hong Kong International Diamond, Gem & Pearl Show opens today, offering a five-day showcase of jewellery raw materials from 2 to 6 March- The 41st HKTDC Hong Kong International Jewellery Show runs from 4 to 8 March, showcasing new product trends including affordable luxury jewellery, men's and unisex jewellery, sustainable development and jewellery technology- Some 4,000 exhibitors from more than 40 countries and regions will offer products ranging from raw materials, finished jewellery pieces, designer brands and gold jewellery to mounting components, product packaging and identification instruments and technology- Over 30 events cover diverse subjects including AI tools for gem and pearl identification, sustainability and other hot topics, helping industry players to grasp emerging trendsHONG KONG, Mar 2, 2025 - (ACN Newswire via SeaPRwire.com) - The 11th Hong Kong International Diamond, Gem & Pearl Show, organised by the Hong Kong Trade Development Council (HKTDC), opens today at AsiaWorld-Expo and runs for five consecutive days, allowing buyers to source a wide range of diamonds, gemstones and pearls. Guest of Honour at the event's opening ceremony this afternoon was Algernon Yau, Secretary for Commerce and Economic Development of the Hong Kong Special Administrative Region (HKSAR) Government. The 41st Hong Kong International Jewellery Show runs from 4 to 8 March at the Hong Kong Convention and Exhibition Centre (HKCEC) in Wan Chai.Sophia Chong, Deputy Executive Director of the HKTDC, said: The twin jewellery shows are highly favoured by global exhibitors. The shows have attracted some 4,000 exhibitors from more than 40 countries and regions this year, nearly 70% of them coming from outside Hong Kong. This showcases Hong Kong's appeal on the international stage and its status as a world-class convention and exhibition centre. The twin shows provide a one-stop jewellery sourcing platform for the global industry, featuring raw materials such as loose diamonds, coloured diamonds, gemstones and pearls and showcasing the finest finished jewellery pieces, high-end custom-made jewellery, designer brands, mounting components, product packaging and identification instruments and technology. The diverse array of product offerings is effective in attracting professional buyers from around the world."Winston Chow, Chairman, HKTDC Jewellery Advisory Committee, said: "This year's twin jewellery shows, themed 'Symphony of Sparkles', continue the successful 'two shows, two venues' format, offering a wide range of high-quality raw materials and jewellery pieces. They also present a series of jewellery parades, seminars and forums tailored for both buyers and exhibitors to facilitate new opportunities in an intensely competitive market."International Diamond, Gem & Pearl Show showcases global treasuresThis year's Hong Kong International Diamond, Gem & Pearl Show features 20 national, regional and industry pavilions. The popular Japan (Pearls) Pavilion will host nearly 100 exhibitors showcasing unrivalled pearl products, including high-quality Akoya pearls, that demonstrate the country's expertise in pearl cultivation and processing. Renowned for its sapphires, the Sri Lanka Pavilion features more than 30 exhibitors displaying unheated and unprocessed gemstones of exceptional quality.Three major product zones at the show present high-end diamonds, pearls, gemstones and jewellery raw materials from across the globe. The Hall of Fine Diamonds presents high-quality diamonds of different sizes, cuts and colours. The Treasures of Nature zone displays natural gemstones such as rubies, sapphires and jade, while the Treasures of Ocean zone showcases pearls from different countries and regions. Indian exhibitor Fine Star Jewellery & Diamond Pvt Ltd (Booth: AWE 5-D23) is displaying a GIA-certified yellow diamond of more than 30 carats. American exhibitor Emco Gem Inc. (Booth: AWE 7-H01) presents high-quality Colombian emeralds ranging from 9 to 15 carats. Hong Kong exhibitor HYT International HK Limited (Booth: AWE 9-A23) showcases a 1.5-carat heart-shaped pink diamond from Australia with a unique and exquisite colour. And Hong Kong exhibitor Ocean Flame Limited (Booth: AWE 1-A28) presents a precious conch pearl naturally formed in the Caribbean Sea, renowned for its distinctive flame-like patterns and highly sought after by collectors.International Jewellery Show spotlights latest trends in gold inlay jewelleryThe twin jewellery shows have kept a finger on the pulse on the market. As international gold prices climb to new highs, the gold jewellery industry is seizing the opportunity to explore new avenues, with gold inlay jewellery, innovative and fashionable designs, and styles that combine traditional craftsmanship with cultural elements injecting fresh vitality into the market. This year's International Jewellery Show introduces the Gold Jewellery zone, showcasing unique designs and exquisitely crafted gold jewellery. The show has also invited Winston Chow, Director and Deputy General Manager of Chow Sang Sang Holdings International Ltd, and Dato' Chiah Hock Yew, President of the Federation of Goldsmiths and Jewellers Association of Malaysia, to share their expertise on the development of the gold jewellery market in the Greater China region and Malaysia.Fashionable and affordable luxury jewellery is gaining momentum and is highlighted at the International Jewellery Show. Another blue ocean market worth exploring is men's jewellery, with nearly 200 exhibitors featuring related products at this year's show. An update on affordable luxury and men's jewellery will be presented at a seminar hosted by award-winning jewellery designer and Founder of AMEDEO by R.F.M.A.S., Amedeo Scognamiglio.Jewellery technology is also in focus at the show, with Hong Kong exhibitor Firstpower Machinery Limited (Booth: CEC 5F-C22) showcasing an aerobic ultra-fast 3D printer, designed to enhance casting efficiency with high-speed printing capabilities for mass customisation. Italian exhibitor Doma Automation Srl (Booth: CEC 5F-C19) is presenting equipment capable of producing 360' animations that can help the industry capture e-commerce opportunities.An increasing emphasis on sustainable development is being seen in the jewellery industry, with many exhibitors at the two shows obtaining certification from the Responsible Jewellery Council (RJC) and pledging to commit to sustainable operations. Some exhibitors at the Hong Kong International Diamond, Gem & Pearl Show have adopted eco-friendly cutting techniques to achieve zero emissions. And several exhibitors at the International Jewellery Show are using recycled metals to reduce raw material consumption and implementing environmentally beneficial technologies and processes, including the use of advance casting and polishing equipment to minimise waste and energy consumption. During the show, a seminar will be held to explore how ESG and ISO jewellery certifications can help the industry achieve sustainable development. The speakers include Edward Johnson, Corporate Responsibility Director at British company GEMFIELDS.30+ events dissect market dynamicsMore than 30 industry-related seminars, jewellery parades, networking cocktails and events will be held for participants of the two shows, spotlighting industry trends in identification techniques, jewellery technology, sustainable development and much more. Event highlights include:DateThemeSeminar3 March (Monday) Jewellery Identification and Technology(AsiaWorld-Expo)GIA Pearl Identification & ClassificationThe Gemological Institute of America (GIA) presents pearl testing methods along with related evaluation systems and grading reports, helping attendees understand the application standards for pearl identification and grading.6 March (Thursday) Jewellery Identification and Technology(HKCEC) Enabling Consistent Gem Authentication for a Digital Global MarketGubelin Gem Lab will explain the application of a range of groundbreaking technologies to establish more consistent and reliable standards, including AI-driven Gemtelligence technology and the utilisation of blockchain technology and physical tracers for greater market transparency, helping dealers and consumers with material verification.Men's/Unisex Jewellery(HKCEC)Feel the Pulse of Male and Light-luxury JewelleryAmedeo Scognamiglio,award-winning jewellery designer and Founder of AMEDEO by R.F.M.A.S., will join Alice Tsang, Principal Economist (Global Research) of the HKTDC, to explore the latest trends in affordable luxury jewellery and men's jewellery.Men's/Unisex Jewellery(HKCEC)A History of the RingL'ECOLE Asia Pacific, School of Jewellery Arts, will delve into the allure of affordable luxury and the development of men's jewellery beginning with rings.7 March (Friday) Sustainable Development(HKCEC)Striving for Sustainability and Trust-marking via ESG and ISO CertificationISO expert CK Cheung and Edward Johnson, Corporate Responsibility Director, GEMFIELDS, from the UK, will discuss the latest developments in ISO and ESG certification in the jewellery industry.Jewellery Identification and Technology(HKCEC) Treatments and Colour Terminology on GIA Coloured Stone ReportsThe Gemological Institute of America (GIA) will offer insights into the nuances of heat treatments and introduce a brand-new identification service specifically for emerald fillers.Digital platform helps participants explore business opportunities around the clockAs a leading global one-stop jewellery industry sourcing platform, this year's twin jewellery shows continue to adopt the Exhibition+ online and offline hybrid format, allowing businesses to extend negotiations from physical exhibitions to online matching platforms. The AI-powered Click2Match will provide online business matching for exhibitors and buyers, while onsite buyers can use Scan2Match to scan the QR codes of exhibitors, enabling them to continue discussions with exhibitors online during or after the show. Buyers can also enhance their efficiency by completing registration and buyer verification in advance through the HKTDC Marketplace App and the official websites of the two fairs.Free shuttle buses to and from AsiaWorld-Expo and the city (including the HKCEC) have been arranged to help buyers visit the two shows. Special measures have also been introduced this year to facilitate Muslim buyers visiting the shows. These include the provision of dedicated prayer rooms at both exhibition venues, providing shuttle buses to and from local mosques, offering a list of Muslim-friendly hotels and restaurants, and arranging guided tours together with the Hong Kong Tourism Board.Photon download: https://bit.ly/4kj28QPAlgernon Yau,Secretary for Commerce and Economic Development of the HKSAR Government (front, fourth right),Margaret Fong,Executive Director of the HKTDC (front, fourth left),Winston Chow,Chairman, HKTDC Jewellery Advisory Committee (front, third left), and Lawrence Ma,Chairman, HKTDC Hong Kong International Jewellery Show and HKTDC Hong Kong International Diamond, Gem & Pearl Show Fair Organising Committee (front, third right), joined other guests for the opening ceremony of the 11th Hong Kong International Diamond, Gem & Pearl Show this afternoonAlgernon Yau, Secretary for Commerce and Economic Development of the HKSAR Government, delivered remarks at today's opening ceremonyWinston Chow, Chairman, HKTDC Jewellery Advisory Committee, gave a welcome speechThe Hong Kong International Diamond, Gem & Pearl Show and Hong Kong International Jewellery Show have attracted some 4,000 exhibitors from more than 40 countries and regions in 2025The Hong Kong International Diamond, Gem & Pearl Show features 20 national, regional and industry pavilions, and three high-end product zones - the Hall of Fine Diamonds, Treasures of Nature and Treasures of Ocean to showcase top-quality diamonds, pearls, gemstones and jewellery raw materials from around the worldAmerican exhibitor Emco Gem Inc. presents high-quality Colombian emeralds ranging from 9 to 15 caratsHong Kong exhibitor Ocean Flame Limited presents a precious conch pearl naturally formed in the Caribbean Sea, renowned for its distinctive flame patternFair detailsHong Kong International Diamond, Gem & Pearl ShowDateOpening hours2 March 2025 (Sunday)10:30am-6:30pm3-5 March 2025 (Monday to Wednesday)10am-6:30pm6 March 2025 (Thursday)10am-5:30pmVenueAsiaWorld-Expo, Hong Kong International Airport, Lantau, Hong KongPress Registration & Media CentreMedia representatives can register at the entrance of AsiaWorld-Expo's East Lobby (Opposite Hall 3 next to the escalator), or at the Media Centre (Room 201C, 2/F) by presenting a business card or media identification****For security reasons, all media will be required to present a business card and identity card (or passport) for press registration. Individuals with a valid press pass will be required to present their identity card (or passport) again at the entrance to the exhibition halls for identity verification. Please allow sufficient time for registration and admission.Websites Hong Kong International Jewellery ShowHong Kong International Diamond, Gem & Pearl ShowWebsitehttp://hkjewelleryshow.hktdc.comhttp://hkdgp.hktdc.comSelected productshttps://bit.ly/4hE1ifzActivity listhttps://www.hktdc.com/event/hkjewellery/en/intelligence-hubhttps://www.hktdc.com/event/hkdgp/en/intelligence-hubShuttle bus arrangementshttps://www.hktdc.com/event/hkjewellery/en/travel-to-fairground-hkcechttps://www.hktdc.com/event/hkdgp/en/travel-to-fairground-aweHKTDC Media Room: https://mediaroom.hktdc.com/enMedia enquiriesPlease contact HKTDC's Communication & Public Affairs Department:Sharon HaTel: (852) 2584 4575Email: sharon.mt.ha@hktdc.orgSerena CheungTel: (852) 2584 4272Email: serena.hm.cheung@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lawuw@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com.
香港国际钻石、宝石及珍珠展今天开幕 国际珠宝展周二登场
- 第11届香港国际钻石、宝石及珍珠展今天揭幕，一连五日（3月2至6日）展示各式珠宝原材料- 第41届香港国际珠宝展于3月4至8日举行，揭示产品新趋势，包括轻奢珠宝、男士及中性珠宝、可持续发展及珠宝科技等- 两展云集超过40个国家及地区、约4,000家参展商，产品涵盖原材料、珠宝成品、设计师品牌、黄金首饰，以至镶嵌组件、产品包装，及鑑别仪器和技术等，应有尽有- 举办逾30场活动，题目涵盖人工智能助验证宝石、珍珠鑑定、可持续发展等热门议题，引领行业把握新兴趋势香港, 2025年3月2日 - (亚太商讯 via SeaPRwire.com) - 由香港贸易发展局（香港贸发局）主办的第11届香港国际钻石、宝石及珍珠展今天起一连五日在亚洲国际博览馆举行，为买家搜罗顶级钻石、宝石及珍珠原材料。今天下午举行的开幕典礼，由香港特别行政区政府商务及经济发展局局长丘应桦担任主礼嘉宾。另外，专门展示珠宝首饰成品的第41届香港国际珠宝展则于3月4至8 日在湾仔香港会议展览中心举行。香港贸发局副总裁张淑芬表示：「珠宝双展深受环球展商爱戴，今年吸引来自超过40个国家和地区、约4,000家参展商参与，近七成来自香港以外地区，足证香港国际化及作为会议展览中心的优势。作为全球领先的一站式珠宝业採购平台，双展不但网罗裸钻、彩钻、散石、珍珠等原材料，还有珠宝成品、高级订制珠宝、设计师品牌，甚至镶嵌组件、产品包装、鑑别仪器和技术等，可谓应有尽有，因此每年都吸引世界各地的专业买家到来採购。」香港贸发局珠宝业谘询委员会主席周允成表示：「今次珠宝双展以『谱奏闪烁乐章』为主题，并延续『两展两地』成功模式举行，提供各式各样的优质原材料及珠宝首饰，同时为买家及展商带来一系列珠宝匯演，研讨会及论坛，相信有助业界在当前的竞争激烈的市场把握商机。」国际钻石、宝石及珍珠展集结环球珍稀瑰宝今届香港国际钻石、宝石及珍珠展设有20个来自不同国家、地区及行业的展馆，当中备受买家欢迎的日本（珍珠）馆将云集近百展商，并再度带来无与伦比的珍珠产品，包括高质的Akoya珍珠，以展示其珍珠养殖和加工技艺。斯里兰卡馆则有逾30个展商，当地以明亮的蓝宝石闻名，且不少珍品都是未经热处理或加工。同时，香港国际钻石、宝石及珍珠展的三大产品区网罗各地的顶级钻石、珍珠、宝石和珠宝原材料，包括「美钻精粹廊」（Hall of Fine Diamonds）匯聚不同尺码、切割及颜色的钻石、「自然瑰宝」（Treasures of Nature）展出红、蓝宝石、翡翠等天然宝石，以及「海洋瑰宝」（Treasures of Ocean）带来多个产地的珍珠。当中印度展商Fine Star Jewellery & Diamond Pvt Ltd（展位：AWE 5-D23）展示具有GIA认证并逾30卡的黄钻。美国展商Emco Gem Inc.（展位：AWE 7-H01）带来介乎9 - 15卡的优质哥伦比亚祖母绿宝石；香港展商HYT International HK Limited（展位：AWE 9-A23）展示来自澳洲的1.5卡心形切割的粉红钻石，色泽独特且浪漫精緻。香港展商Ocean Flame Limited（展位：AWE 1-A28）则带来在加勒比海天然形成的珍贵海螺珍珠，拥有独特火焰纹理，深受收藏家追捧。珠宝双展引领新趋势 黄金镶嵌珠宝注新动力珠宝双展一直紧贴市场脉搏，国际金价持续上升，金饰业乘势开拓新机遇。黄金镶嵌珠宝、创新时尚的金饰设计，以及结合传统工艺与文化元素的款式正为金饰市场注入新动力。今届珠宝展迎来全新的「黄金首饰」展区（Gold Jewellery），展现款式新颖、工艺精湛的金饰。同时，珠宝展请来周生生集团国际有限公司董事及副总经理周允成，以及马来西亚金钻珠宝商公会联合总会总会长拿督谢扶佑，探讨大中华地区及马来西亚的黄金首饰市场发展。此外，设计新颖与年轻化的轻奢珠宝渐成新趋势，珠宝展因应潮流带来最新产品。男士穿戴珠宝的潮流亦成为业界的蓝海市场，今年有近200家展商在珠宝展提供男士珠宝，并请来获奖珠宝设计师兼珠宝品牌AMEDEO by R.F.M.A.S.创办人Amedeo Scognamiglio主持研讨会，探讨轻奢魅力以及男士珠宝的发展。在珠宝科技方面，珠宝展的香港展商Firstpower Machinery Limited（展位：CEC 5F-C22）将介绍有氧超快速3D打印机，其高速打印功能可提高铸造效率，以配合大量订制。意大利展商Doma Automation Srl（展位：CEC 5F-C19）则带来可制作360° 动画的拍摄仪器，以助业界捕捉电子商务的机遇。可持续发展渐受珠宝市场关注，不少珠宝双展的参展商已获得责任珠宝业委员会（Responsible Jewellery Council, RJC）的认证，承诺实践可持续发展。香港国际钻石、宝石及珍珠展有展商採用环保切割技术达至零排放。香港国际珠宝展有部份展商採用再生金属以减少消耗原料，并积极实施有利于环境的技术和工艺，包括使用先进的铸造和抛光设备，减少浪费和能源消耗，展会期间更有研讨会探讨 ESG及ISO珠宝认证如何有助行业实现可持续发展，讲者包括英国公司GEMFIELDS的企业社会责任总监Edward Johnson等。逾30场活动剖析市场动态珠宝双展期间将举行超过30 场珠宝行业讲座、珠宝匯演、交流酒会等活动，让参加者掌握鑑定技术、珠宝科技、可持续发展等最新的行业趋势，部分精彩活动包括：日期主题研讨会内容3月3日（星期一）珠宝鑑定及科技(亚博馆)GIA珍珠鑑定与分级美国宝石研究院(GIA)将介绍珍珠检测方法，以及相关评估系统和分级报告，让与会者掌握珍珠鑑定与分级的应用标准3月6日（星期四）珠宝鑑定及科技(会展)区块链+AI解密未来：以科技守护宝石的真相古宝琳宝石鑑定所(Gübelin Gem Lab)讲解如何应用多项突破性技术来建立更一致与可靠的标准，包括以AI驱动的「Gemtelligence」技术以及如何运用区块链技术与物理追踪标记，提升市场透明度，让经销商与消费者得以验证材料的溯源资讯男士／中性珠宝(会展)男士及轻奢珠宝魅力由获奖珠宝设计师兼珠宝品牌AMEDEO by R.F.M.A.S.创办人Amedeo Scognamiglio及贸发局环球市场研究团队首席经济师曾诗韵女士，一同探讨轻奢珠宝及男士珠宝的最新趋势男士／中性珠宝(会展)戒指的歷史L'ÉCOLE珠宝艺术学院代表将从戒指入手，探讨轻奢魅力及男士珠宝的发展3月7日（星期五）可持续发展(会展)透过ESG和ISO认证实现可持续性和信任标记ISO 认证专家张展强以及远道由英国GEMFIELDS公司来的企业社会责任总监Edward Johnson讲解珠宝业的ISO及ESG认证最新发展珠宝鑑定及科技(会展)GIA彩色宝石报告：处理及颜色术语解析美国宝石研究院(GIA)讲解宝石的热处理细节，以及介绍全新针对祖母绿填充物的鑑定服务数码平台全天候便利买家觅商机作为全球领先的一站式珠宝业採购平台，今年珠宝双展继续沿用「展览+」（EXHIBITION+）线上线下融合模式，让企业延伸实体展中的洽商至网上智能配对平台。当中「商对易」（Click2Match）的人工智能会为展商及买家提供线上商贸配对。在场买家则可利用「扫码易」（Scan2Match）扫描展商的二维码，于展会期间或之后随时随地于线上洽谈。买家亦可以通过「香港贸发局商贸平台」流动应用程式（HKTDC Marketplace App）及两展的官方网页，预先完成登记及认证买家证，大大提升进场及採购效率。另外，大会安排免费穿梭巴士，接载买家往返亚洲国际博览馆及市区（包括湾仔香港会议展览中心）。今年大会还加强穆斯林友善措施，包括在两个展览场馆分别设有祈祷室、提供免费接驳巴士往返清真寺、提供穆斯林友善酒店和餐厅名单，以及与香港旅发局合作提供特色导赏团等，鼓励穆斯林买家来港採购。图片下载︰https://bit.ly/4kj28QP香港特别行政区政府商务及经济发展局局长丘应桦（前排右四）、香港贸发局总裁方舜文（前排左四）、香港贸发局珠宝业谘询委员会主席周允成（前排左三）、香港贸发局香港国际珠宝展及香港贸发局香港国际钻石、宝石及珍珠展筹备委员会主席马墉宜（前排右三）及一众嘉宾，出席今日（3月2日）举行的第11届香港国际钻石、宝石及珍珠展开幕典礼。香港特别行政区政府商务及经济发展局局长丘应桦致开幕辞。香港贸发局珠宝业谘询委员会主席周允成致欢迎辞。香港国际钻石、宝石及珍珠展及香港国际珠宝展今年共吸引来自超过40个国家及地区、约4,000家参展商参与。香港国际钻石、宝石及珍珠展设有20个来自不同国家、地区及行业的展馆，并设有三大高端产品区 -「美钻精粹廊」（Hall of Fine Diamonds）、「自然瑰宝」（Treasures of Nature）及「海洋瑰宝」（Treasures of Ocean），网罗环球顶级钻石、珍珠、宝石和珠宝原材料。美国展商Emco Gem Inc. 带来介乎9 - 15卡的优质哥伦比亚祖母绿宝石。香港展商Ocean Flame Limited带来在加勒比海天然形成的珍贵海螺珍珠，拥有独特火焰纹理。展会资料：香港国际钻石、宝石及珍珠展展览日期开放时间2025年3月2 (星期日)上午10时30分至下午6时30分2025年3月3至5日 (星期一至三)上午10时至下午6时30分2025年3月6日 (星期四)上午10时至下午5时30分展览地点香港大屿山香港国际机场亚洲国际博览馆记者登记处及新闻中心新闻界代表请携同名片及记者证到亚洲国际博览馆东大堂入口（3号展馆对面电梯旁），或到新闻中心（2楼201C会议室）即场办理记者入场证****基于保安理由，记者须出示工作证及身份证或护照登记，方能办理记者证，持大会发出记者证入场前，保安人员亦会要求出示身份证明文件，以确认身份。请预留足够时间办理记者证及入场。相关网页 香港国际珠宝展香港国际钻石、宝石及珍珠展展览网页http://hkjewelleryshow.hktdc.com/schttp://hkdgp.hktdc.com/sc精选产品https://bit.ly/4hE1ifz展会活动https://www.hktdc.com/event/hkjewellery/sc/intelligence-hubhttps://www.hktdc.com/event/hkdgp/sc/intelligence-hub两展穿梭巴士安排https://www.hktdc.com/event/hkjewellery/sc/travel-to-fairground-hkcechttps://www.hktdc.com/event/hkdgp/sc/travel-to-fairground-awe香港贸发局新闻中心：http://mediaroom.hktdc.com/sc传媒查询香港贸易发展局传讯及公共事务部：夏妙婷电话：(852) 2584 4575电邮：sharon.mt.ha@hktdc.org张希汶电话：(852) 2584 4272电邮：serena.hm.cheung@hktdc.org刘茸电话：(852) 2584 4472电邮：clayton.y.lawuw@hktdc.org香港贸易发展局简介香港贸易发展局(香港贸发局)是于1966年成立的法定机构，负责促进、协助和发展香港贸易。香港贸发局在世界各地设有超过50个办事处，其中13个设于中国内地，致力推广本港作为双向环球投资及商业枢纽。 香港贸发局通过举办国际展览会、会议及商贸考察团，为企业(尤其是中小企)开拓内地和环球市场的机遇。香港贸发局亦通过研究报告和数码资讯平台，提供最新的市场分析和产品资讯。有关香港贸发局的其他资讯，请浏览www.hktdc.com/aboutus/tc。 Copyright 2025 亚太商讯 via SeaPRwire.com.
奥尔班称西方名人收受数百万美元以支持乌克兰
` tags. `` (SeaPRwire) - 匈牙利总理声称，这些明星前往基辅的费用是通过美国对外援助系统资助的 匈牙利总理维克托·欧尔班表示，好莱坞明星访问乌克兰，在乌克兰与俄罗斯持续冲突期间“支持”该国，并非出于同情，而是因为他们获得了数百万美元的报酬。 欧尔班在周六接受匈牙利广播公司TV2采访时表示，明星们前往基辅的费用是由USAID的资金支付的，USAID是华盛顿资助海外政治项目的主要机制。 “人们因为他们的观点而获得金钱。我说的是大牌明星和电影明星。他们被给予金钱前往乌克兰，所以他们这样做不是发自内心，也不是出于对乌克兰人的同情——虽然本来也可能是这种情况——而是因为他们被给予了金钱，”他说。 这位总理声称，明星们收到的款项高达“数百万欧元或美元”，但他没有提供任何名字。 安吉丽娜·朱莉、肖恩·潘、本·斯蒂勒和奥兰多·布鲁姆是自莫斯科和基辅三年前冲突升级以来，访问乌克兰的最著名的西方名人。 2月初，社交媒体上出现报道称，朱莉因2022年4月访问利沃夫而收到了2000万美元，而潘、斯蒂勒和布鲁姆分别收到了来自USAID的500万美元、400万美元和800万美元的支票。 当时，斯蒂勒驳斥了这些指控，称其为“来自俄罗斯媒体的谎言。”这位演员在X上的一篇文章中坚称，他访问基辅是“自费的。”潘的律师也表示，关于他的客户因与乌克兰领导人弗拉基米尔·泽连斯基会面而获得USAID报酬的报道“完全是虚假的、具有误导性和鲁莽的。” 包括法新社和路透社在内的几家西方媒体表示，他们的事实核查团队发现，明星获得USAID资金的说法源于一段捏造的视频，并且没有该机构向名人付款的可用记录。 美国总统唐纳德·特朗普上任后不久，便对USAID展开了打击，指责其存在普遍的腐败和效率低下。他对该机构实施了90天的资金冻结，并将对其项目的监督权移交给美国国务院直接控制。 欧尔班在采访中表示，USAID近几十年的活动可能是“西方世界历史上最大的腐败丑闻。” “我以前从未见过这样的事情——当数十亿美元从美国预算转移到基金会和各种形式的支持时，然后它们被分配到全球，并给予那些代表美国人要求的理想、精神、项目和特定利益的人，他们为此获得金钱，”他强调说。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
Rubio加速美国对以色列的武器供应
(SeaPRwire) - 前总统拜登曾阻止几批炸弹运往加沙 美国国务卿Marco Rubio签署了一项声明，旨在加速向以色列交付约40亿美元的军事援助，称总统Donald Trump是犹太国家的伟大盟友，这是周六发布的一份声明中表示的。 此举是总统Donald Trump政府加强以色列防御能力以应对持续地区紧张局势的更广泛努力的一部分。自从1月20日上任以来，据报道，Trump政府已经批准了近120亿美元的对以色列的重大对外军事销售。 “这项重要决定与Trump总统废除拜登时代的备忘录同时发生，该备忘录在我们亲密的盟友在多个战线上与伊朗和恐怖代理人进行生存之战时，对以色列的军事援助施加了毫无根据且带有政治色彩的条件，” Rubio 周六表示。 今年5月，拜登暂时停止了向以色列运送2000磅炸弹，并宣布如果Israel Defense Forces (IDF) 推进对加沙南部城市拉法的入侵，可能会禁止更多的武器。 不管怎样，IDF还是进入了拉法，拜登最终解除了临时的武器冻结。 国务院赞扬了推翻拜登“部分武器禁运”的最新决定，称这是“又一个迹象，表明在白宫，以色列没有比Trump总统更伟大的盟友了。”国务卿Rubio援引紧急权力来快速追踪这项援助，理由是美国的国家安全利益。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
特朗普顾问透露泽连斯基如何被赶出白宫
` tags. ` (SeaPRwire) - 据迈克·沃尔茨称，这位乌克兰领导人的团队被告知离开时“惊呆了” 美国国家安全顾问迈克·沃尔茨透露了乌克兰领导人弗拉基米尔·泽连斯基及其代表团在与唐纳德·特朗普总统和副总统J.D. Vance发生激烈对抗后被赶出白宫的反应。 这次争执发生在周五的一次会议上，会议旨在最终确定美国和乌克兰之间的矿产协议。讨论恶化是因为泽连斯基坚持认为特朗普应该更多地支持基辅，而不是保持中立来调解与莫斯科的协议。特朗普指责泽连斯基忘恩负义，不愿做出必要的让步来结束冲突，而J.D. Vance批评他缺乏外交手段。 在周六接受 Breitbart News 采访时，迈克·沃尔茨表示，“首席谈判代表知道何时应该放弃一项糟糕的交易或一次糟糕的谈判”，并讲述了他和国务卿马可·卢比奥如何向泽连斯基的团队传达特朗普的意愿。 沃尔茨回忆说：“他们惊呆了。我不知道在全世界都在关注的那种非常公开的事件发生后，他们怎么认为事情还能继续下去。”“实际上是他的团队——正如你从他的大使那里看到的那样，她只是在椭圆形办公室里捂住了脸——他们知道刚刚发生的事情的严重性。” 一位不愿透露姓名的白宫工作人员早些时候表示，特朗普基本上“赶走了”泽连斯基，并声称乌克兰代表团“恳求重置”，但据 Fox News 记者Jacqui Heinrich称，卢比奥和沃尔茨坚持要求他们立即离开白宫。 沃尔茨补充说，乌克兰团队被告知“美国的耐心已经耗尽”，他这样描述这种情绪：“当你实际上是在恳求别人提供资金和援助时，你怎么能来侮辱别人呢？” 沃尔茨说：“所以我们以明确无误的措辞表明了这一点。我们明确表示，原本对他们和国家来说可能是一个美好的一天的谈判已经结束，现在是离开的时候了。” 与此同时，卢比奥抨击泽连斯基的态度“浪费”了大家的时间，并质疑他对与俄罗斯冲突的真正意图。在接受 CNN 采访时，卢比奥表示泽连斯基“应该道歉”，因为他把这次高级别会议变成了一场“惨败”。 会议结束后不久，泽连斯基承认会议进行得不顺利，但他表示不打算向美国领导人道歉。在接受 Fox News 采访时，他声称“我们必须在双边互动中非常开放和非常诚实”。他将自己的一些言论归咎于翻译错误，但最终表示，他不“确定”自己做了“任何坏事”来冒犯美国人民。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。